Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Gallipoli

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Blood|November 10, 2022
AML gets upSET when its dietary needs are unMetPaolo Gallipoli
Leukemia Research|November 6, 2018
JAK of all trades: Ruxolitinib as a new therapeutic option for CML patientsPaolo Gallipoli
Frontiers in Oncology|June 7, 2021
The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid LeukemiaVilma Dembitz, Paolo Gallipoli
European Journal of Haematology|November 21, 2008
Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemiaPaolo Gallipoli, M W Drummond
British Journal of Haematology|November 28, 2008
Multiple splenic calcificationsAndrew J Fyfe, Paolo Gallipoli
Science (New York, N.Y.)|March 16, 2019
Histone modifiers are oxygen sensorsPaolo Gallipoli, Brian J P Huntly
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2018
Prognostic Models Turn the Heat(IT)up on <i>FLT3<sup>ITD</sup></i> -Mutated AMLPaolo Gallipoli, Brian J P Huntly
Seminars in Cancer Biology|August 8, 2017
Novel epigenetic therapies in hematological malignancies: Current status and beyondPaolo Gallipoli, Brian J P Huntly
American Journal of Hematology|August 29, 2009
The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemiaPaolo Gallipoli, Andrew Clark, Mike Leach
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2014
Thrombosis and hemostatic abnormalities in hematological malignanciesRiccardo Colombo, Paolo Gallipoli, Roberto Castelli
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Blood|November 10, 2022
AML gets upSET when its dietary needs are unMetPaolo Gallipoli
Leukemia Research|November 6, 2018
JAK of all trades: Ruxolitinib as a new therapeutic option for CML patientsPaolo Gallipoli
Frontiers in Oncology|June 7, 2021
The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid LeukemiaVilma Dembitz, Paolo Gallipoli
European Journal of Haematology|November 21, 2008
Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemiaPaolo Gallipoli, M W Drummond
British Journal of Haematology|November 28, 2008
Multiple splenic calcificationsAndrew J Fyfe, Paolo Gallipoli
Science (New York, N.Y.)|March 16, 2019
Histone modifiers are oxygen sensorsPaolo Gallipoli, Brian J P Huntly
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2018
Prognostic Models Turn the Heat(IT)up on <i>FLT3<sup>ITD</sup></i> -Mutated AMLPaolo Gallipoli, Brian J P Huntly
Seminars in Cancer Biology|August 8, 2017
Novel epigenetic therapies in hematological malignancies: Current status and beyondPaolo Gallipoli, Brian J P Huntly
American Journal of Hematology|August 29, 2009
The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemiaPaolo Gallipoli, Andrew Clark, Mike Leach
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2014
Thrombosis and hemostatic abnormalities in hematological malignanciesRiccardo Colombo, Paolo Gallipoli, Roberto Castelli
Pageof 7